Kepler Capital analyst David Evans maintained a Buy rating on Novartis AG on April 2 and set a price target of CHF135.00. The company’s shares clos......

President Donald Trump on Thursday signed an executive order to impose a 100% tariff on imported branded medicines (patented drugs and their active......

In a report released today, James Quigley from Goldman Sachs maintained a Sell rating on Novartis AG, with a price target of CHF105.00. Quigley cov......

Nevada Sunrise Gold ( ($TSE:NEV) ) just unveiled an update. Nevada Sunrise Metals has identified new gold-in-soil anomalies at its Griffon Gold Min......

Barclays analyst James Gordon CFA maintained a Hold rating on Novartis AG today and set a price target of CHF120.00. According to TipRanks, Gordon ......

Barclays analyst James Gordon CFA maintained a Hold rating on Novartis AG yesterday and set a price target of CHF120.00. The company’s shares close......

Goldman Sachs analyst James Quigley maintained a Sell rating on Novartis AG today and set a price target of CHF101.00. According to TipRanks, Quigl......

Novartis received a Hold rating and price target from Bernstein analyst Justin Smith today. According to TipRanks, Smith is a 4-star analyst with a......

An announcement from Novartis ( ($NVS) ) is now available. On March 18, 2026, Novartis AG filed a Form 6-K in the United States reporting a major U......

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Warby Parker (WRBY) and Annovis Bio (ANVS) with bull......